| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA805: Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides |
|
Medicine details |
|
| Medicine name | icosapent ethyl (Vazkepa®) |
| Formulation | 998 mg soft capsules |
| Reference number | 4859 |
| Indication | Indicated to reduce cardiovascular risk as an adjunct to statin therapy |
| Company | Amarin Pharma Inc |
| BNF chapter | Cardiovascular system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 20/04/2021 |
| NICE guidance | |